Abstract
Historically, advanced oropharyngeal cancer has been treated by surgical excision and postoperative radiotherapy. In this decade, many authors advocate for chemoradiotherapy to avoid impairments after surgery. But it also induced significant impairments in swallowing. Transoral robotic surgery (TORS) provides new benchmarks of function and complication rates, with which other series of treatments for oropharyngeal SCC can be compared. In Japan, we cannot do this procedure now, but we have to prepare.
| Original language | English |
|---|---|
| Pages (from-to) | 349-352 |
| Number of pages | 4 |
| Journal | Oto-Rhino-Laryngology Tokyo |
| Volume | 54 |
| Issue number | 5 |
| Publication status | Published - 2011 Oct 15 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Dysphagia
- Organ preservation
- Oropharyngeal cancer
ASJC Scopus subject areas
- Otorhinolaryngology
Fingerprint
Dive into the research topics of 'Transoral robotic surgery'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS